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ABSTRACT
The physiological processes that maintain body homeostasis
oscillate during the day. Diurnal changes characterize kidney
functions, comprising regulation of hydro-electrolytic and
acid-base balance, reabsorption of small solutes and hormone
production. Renal physiology is characterized by 24-h period-
icity and contributes to circadian variability of blood pressure
levels, related as well to nychthemeral changes of sodium sen-
sitivity, physical activity, vascular tone, autonomic function
and neurotransmitter release from sympathetic innervations.
The circadian rhythmicity of body physiology is driven by
central and peripheral biological clockworks and entrained by
the geophysical light/dark cycle. Chronodisruption, deﬁned as
the mismatch between environmental–social cues and physio-
logical–behavioral patterns, causes internal desynchronization
of periodic functions, leading to pathophysiological mechan-
isms underlying degenerative, immune related, metabolic and
neoplastic diseases. In this review we will address the genetic,
molecular and anatomical elements that hardwire circadian
rhythmicity in renal physiology and subtend disarray of time–
dependent changes in renal pathology.
INTRODUCTION
All living things that populate the Earth’s surface must cope
with unpredictable environmental changes that may alter their
ecological niches, as well as with predictable changes related to
the geophysical 24-h day causing solar lighting alternation
and temperature rise and fall [1]. The earliest forms of life
were represented by organisms without spatial boundaries to
take apart redox reactions, respiration and nitrogen-ﬁxing
activity, which are biochemically unable to coexist, and were in
that case separated in the temporal dimension [2]. Above and
beyond the compartmentalization of chemically incompatible
pathways to different time windows, living forms had to
escape harmful photo-oxidative consequences of exposure to
the environmental light, caused by absence of extensive ozone
layer, preordaining at night light-sensitive reactions, such as
© The Author 2013. Published by Oxford University Press on
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DNA synthesis, to preserve them from the solar ionizing
radiation [2, 3]. Life forms manage periodic environmental
changes with anticipatory phenomena of physiology and be-
havior, entrained principally by the light/dark cycle and in
turn the synchronization of organism functions to the daily al-
ternation of dusk and dawn is critical for maintenance of
healthiness and wellbeing. Besides, other factors that power-
fully inﬂuence timing of biological processes are represented
by temperature changes and metabolic ﬂux related to feeding.
The neurons of the central nervous system are rather resilient
to these stimuli, whereas other organs, such as liver and
kidney, are very responsive, so that rescheduling of feeding
time or feeding a particular diet disengages metabolic path-
ways from the light/dark cycle [4, 5]. Body homeostasis relies
on the activity of physiological processes that oscillate during
the day, among the others those leading to circadian variation
of blood pressure levels, related to physical activity, autonomic
function and sympathetic innervation, vascular tone, sodium
sensitivity [6], as well as renal physiology, characterized by
time-related variations of functions including the regulation of
hydro-electrolytic and acid–base balance, reabsorption of
small solutes, hormone production, vitamin D activation and
ultimately blood pressure regulation [7].
The well-timed organization of the array of ﬂuctuations is
overridden when behavioral patterns of sleep–wake, rest/
activity and fasting/feeding, as well as anabolic/catabolic pro-
cesses are untimely settled with respect to the natural photo-
period by light exposure at night or shift work. The mismatch
between environmental–social cues and physiological–behavioral
patterns is deﬁned chronodisruption and leads to internal de-
synchronization among a number of periodic functions, which
may be involved in physiopathological mechanisms under-
lying degenerative, immune related, metabolic and neoplastic
diseases [8].
THE MOLECULAR CLOCKWORK AND THE
CIRCADIAN TIMING SYSTEM
The periodicity of biological processes and physiological
phenomena is generated by evolutionarily conserved molecu-
lar clockworks, ticking autonomously in each cell and working
through a transcriptional/translational feedback loop operated
by a set of genes and their encoded proteins [9] (Figure 1).
They are called clock genes and are represented by CLOCK,
and its paralog NPAS2, ARNTL-2/BMAL1-2, PERIOD (PER1-
3) and CRYPTOCHROME (CRY1-2) (Table 1). CLOCK and
BMAL1 switch on the positive limb of the loop, encoding the
transcription factors CLOCK and BMAL1 that heterodimerize
and bind to E-boxes in the promoters of PER1-3 and CRY1-2,
which in turn code for proteins that inhibit the transcriptional
activity of CLOCK:BMAL1, closing the loop in a near-24-h
period (deﬁned circadian, from the latin circa, about, and dies,
day) [10]. CLOCK:BMAL1 heterodimer drives also the
expression of genes encoding the nuclear receptors REV-
ERBα/β and RORα/γ, which play a key role in the molecular
clockwork, driving the expression of BMAL1 in a negative and
positive manner, respectively, binding to the same responsive
element, and conferring robustness and amplitude of func-
tioning to the biological oscillator [11]. The oscillation of the
molecular clock relies also on post-translational modiﬁcations
of circadian proteins operated by processes of phosphoryl-
ation, mediated by casein kinases 1-δ and 1-ɛ (CK1δ and
CK1ɛ), glycogen synthase kinase 3 β and adenosine mono-
phosphate (AMP) activated kinase (AMPK), ubiquitination
mediated by the E3 ubiquitin ligase complex β-TrCP1 and
SCF/Fbxl3 ubiquitin ligase complex, and sumoylation by
SUMO2/3 [12–14]. Another process is represented by acety-
lation, which is involved also in epigenetic changes, is
mediated by the acetylase activity of CLOCK on BMAL1, and
is counteracted by SIRT1, a type III NAD+-dependent protein/
histone deacetylase (HDAC). NAD+ levels ﬂuctuate according
to the circadian rhythmicity of expression of NAMPT/visfatin/
PBEF, the rate-limiting enzyme driving the NAD+ salvage
pathway [15]. Besides, SIRT1 and HDAC3 regulate the func-
tioning of the clock gene machinery driving the circadian
rhythm of histone deacetylation [16]. At the moment there is
uncertainty about the function of the circadian gene Timeless
(Tim), ﬁrst discovered in Drosophila melanogaster and con-
served in mammals, which encodes the protein TIM that
associates with TIMELESS interacting protein (TIPIN) and
regulates DNA replication processes, playing a key role in the
DNA replication system [17].
The bHLH transcription factors DEC1 and DEC2 hinder
E-box-mediated transcription, repressing/regulating the circa-
dian transcription of numerous core clock genes and clock-
controlled genes. On the other hand, DEC1 and DEC2 gene
transcription is activated by CLOCK:BMAL1 heterodimer,
and the encoded DEC proteins show robust circadian rhyth-
micity, playing a key role in the molecular clockwork [18].
The clock genes drive the expression of clock-controlled
genes and tissue-speciﬁc output genes that regulate cell, tissue
and organ function, and 2–20% of the transcriptome shows
circadian rhythmicity, as evidenced by 24-h gene expression
proﬁling. The rhythmic transcription of output genes is
mostly regulated by the clock-controlled PAR bZip transcrip-
tion factors DBP, HLF and TEF [3, 19, 20]. A coherent phase
of oscillation among the biological clocks is dictated by the cir-
cadian timing system, comprising a central pacemaker in the
suprachiasmatic nuclei (SCN), entrained to the light/dark
cycle by photic inputs conveyed by the retino-hyoptalamic
tract, and driving self-sustained cell-autonomous oscillators in
the peripheral tissues through outputs that are neural (auto-
nomic nervous system) and humoral (melatonin, cortisol)
[21]. The entrainment of peripheral oscillators to light/dark
cycle depends on the direct output conveyed by sympathetic
and parasympathetic nerve ﬁbers targeting peripheral tissues,
and the light-induced changes in the expression patterns of
the clock gene machinery are organ and time-of-day speciﬁc
[22]. In both diurnal and nocturnal mammals melatonin is
synthesized only at night by the pineal gland [23], whose circa-
dian rhythmicity of secretion is driven by the SCN that express
high-afﬁnity melatonin receptors, so that the pineal hormone
feedbacks on the SCN [24]. RORα has been proposed as candi-
date nuclear receptor of melatonin, which promotes a time-
dependent decrease in its nuclear levels and changes in its
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transcriptional activity [25]. Regarding cortisol, glucocorticoids
bind to GRs and engage genomic glucocorticoid response
elements within the core clock gene PER1, inﬂuencing its tran-
scription and precisely inducing its expression [26].
THE CLOCK GENE MACHINERY IN RENAL
PHYSIOLOGY
While partners of the clock gene machinery (including
transcription factors BMAL1, CLOCK, PERs, CRYs and REV-
ERBs) are ubiquitously expressed and participate in the main-
tenance of peripheral clock function, their role in speciﬁc
organs, and more speciﬁcally in the kidney, are just starting to
be unveiled [27]. In the same way, the mechanism of synchro-
nization between the central and peripheral clocks such as the
kidney is still being determined. Neuronal and humoral
signals are likely to play a key role [28]. As a key regulator of
the circadian clock, the nuclear orphan receptor REV-ERBα
has recently been proposed as a synchronizing hinge among
the peripheral clocks [29, 30]. Compelling evidence demon-
strated that REV-ERBα, alone among the key circadian genes,
was expressed in a similar manner with the same peak in
expression in several peripheral tissues. Further investigation
into the mechanism of REV-ERBα action in the kidney should
contribute to our understanding of clock function in renal
tissue.
In the kidney, numerous circadian rhythms are present, in-
cluding for renal blood ﬂow, glomerular ﬁltration rate and
various tubular functions involved in secretion and reabsorp-
tion. While these rhythms have been described for decades, it
has been difﬁcult to understand the molecular mechanisms
that are controlling them, especially in the context of many
confounding and interconnected factors, such as hormones or
changes in blood pressure for the most obvious ones.
More recently, several attempts to reveal the role of the
molecular clock in the kidney have been made, especially by
using mouse models in which components of the molecular
clock have been knocked out. It should be noted that rodents
are nocturnal animals, being active during the night and
resting during the day, and this difference should be accounted
for when human physiology is considered.
Recent studies involving the kidney shed some light on the
regulation of clock gene expression by food and light cues in
this tissue. Wu et al. [31] looked at the ability of the kidney to
reset expression of circadian clock genes following manipu-
lation of the normal circadian rhythm by reversal of the light:
dark cycle, reversal of the feeding cycle or a combination of
both maneuvers. Reversal of the food cue had a weak synchro-
nizing effect on clock gene expression in the kidney, whereas
F IGURE 1 : Schematic representation of the molecular clockwork. The transcription factors CLOCK and BMAL1 heterodimerize and bind to
E-box enhancer elements in the promoters of PER1-3 and CRY1-2, which drive the negative limb in the feedback loop. PER and CRY proteins
are phosphorylated (Ph) by casein kinase (CK), translocate back into the nucleus, hampering CLOCK and BMAL1 transcriptional activity. CK
and AMP kinase (AMPK) target PER and CRY, respectively, for degradation. CLOCK:BMAL1 heterodimer activates the expression of the
nuclear receptor REVERBs, RORs, PPARs, the transcription factors DBP, HLF, TEF, DEC and the clock-controlled genes, which drive cell, tissue
and organ functions. An assisting loop is driven by REV-ERBs, which activate E4BP4 transcription and negatively control the rhythmic
transcription of BMAL1 impeding RORs binding at the response elements.
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reversal of the light:dark cycle affected only PER1 expression.
The combination of light and feeding reversal caused PER1
and CLOCK expression to be shifted by 12 h, suggesting the
importance of PER1 and CLOCK to the setting of renal
circadian rhythms. A follow-up study looked at the effect of a
30-min feeding stimulus (following 24 h of fasting) on circa-
dian clock gene expression in the heart and kidney [32]. In the
heart, mRNA levels of BMAL1, CRY1, PER1 and PER2 were
uniformly decreased in animals given the 30-min feeding
stimulus, but in the kidney only expression of PER1 differed
signiﬁcantly from control mice that did not receive a feeding
stimulus. These results together suggest that the kidney is less
sensitive to feeding cues compared with other tissues and illus-
trate the importance of alterations in PER1 levels. Although
the kidney appears to be less sensitive to food cues, it is inter-
esting to note that in both studies, the PER1 gene was the most
sensitive to changes in light and feeding cues. These studies
were performed using whole kidney RNA samples. Future
studies directed at the effects of light and feeding cues on
nephron segments or individual epithelial transport mechan-
isms should be very informative.
Zuber et al. [33] addressed the role of the circadian timing
system in the distal tubular function by microdissecting the
mouse distal convoluted and connecting tubules (DCT–CNT)
on the one hand and the cortical collecting ducts (CCD) on
the other hand every 4 h for 24 h. Microarray analysis was per-
formed and gene expression proﬁle analysis over 24 h showed
that 3814 (DCT–CNT) and 2112 (CCD) genes displayed
cyclic changes with an amplitude >1.8-fold. While all genes,
taken together, present an acrophase (the peak expression)
randomly distributed over 24 h, some categories of genes
showed preferential expression at deﬁnite time. For instance,
the large family of solute carriers (SLC family) or the metabo-
lizing enzyme family of cytochrome showed coordinated peak
expression at ZT12, the period when the mice start being
active and start eating (ZT0 represents the time at which the
light is switch on, starting the period of inactivity for mice,
while ZT12 is the time at which the light is switched off ). This
observation indicates that the peak expression of solute trans-
porters and of enzymes needed for metabolizing xenobiotics
and nutriments are perfectly synchronized with the time at
which the burden of absorbed ions are ﬂooding the kidney
and at which needs for enzymatic processes are increased.
Another example of coordinated expression of genes acting on
the same functional pathway in the kidney is given for water
reabsorption. The acrophase of the mRNA expression of V2R
is perfectly coordinated with the acrophase of the effectors
AQP2 and AQP4, and αENaC at ZT20. Time-controlled
expression of genes involved in a same physiological function,
but structurally different, suggests a critical role of the molecu-
lar clock in coordinating this function [33]. Anticipation of
the work load by increasing the expression of the main effec-
tors ahead of the time at which the load is expected allows a
better control, decreases the amplitude of reactivity of feedback
loops and strengthens homeostasis. This illustrates the concept
of predictive homeostasis as coined by Moore-Ede [34].
Circadian clock-mediated regulation of gene expression
in the kidney
Salt preservation implies several transporters and regulat-
ory mechanisms. In the proximal tubule, the majority of trans-
cellular sodium reabsorption is mediated by NHE3, which was
Table 1. Non-standard abbreviations and
acronyms
CLOCK Circadian locomotor output cycles kaput
ARNTL-2 Aryl-hydrocarbon receptor nuclear
translocator-like
BMAL1-2 Brain and muscle aryl-hydrocarbon
receptor nuclear translocator-like
NPAS2 Neuronal PAS domain protein 2
REV-ERBα Reverse transcript of erythroblastosis gene α
RORα Retinoic acid-related (RAR) orphan
receptor α
β-TrCP1 β-transducin repeat containing protein 1
SCF/Fbxl3 Skp1, Cullin1, F-box and leucine-rich
repeat protein 3
NAMPT Nicotinamide phosphoribosyltransferase
PBEF Pre-B-cell colony-enhancing factor
bHLH Basic helix-loop-helix
DEC1 Differentially expressed in chondrocytes
protein 1
DEC2 Differentially expressed in chondrocytes
protein 2
PAR bZip Proline- and acid-rich basic region leucine
zipper
DBP Albumin D-site binding protein
HLF Hepatic leukemia factor
TEF Thyrotroph embryonic factor
V2R Receptor to vasopressin
AQP2 Aquaporin-2
AQP4 Aquaporin-4
NHE3 Sodium-proton (Na, H) exchanger
αENaC Renal epithelial sodium channel
ET-1 Endothelin-1
HKα2 HKα2-containing H,K-ATPase
ERRβ estrogen-related receptor β
NKCC2 SLC12A1 (sodium/potassium/chloride
transporters), member 1
HETE Hydroxyeicosatetraenoic acid
NCC SLC12A3 NaCl cotransporter
REN-2 Renin 2
PAI-1 Plasminogen activator inhibitor type 1
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the ﬁrst renal epithelial transporter to be linked to the molecu-
lar clockwork [35] (Figure 2). NHE3 mRNA and protein
expression in the kidney exhibits a circadian pattern, tightly
regulated by the clock gene machinery through direct binding
of the CLOCK:BMAL1 heterodimer on the E-box of the gene
promoter. In particular, NHE3 peak expression (at a protein
level) at ZT16-20 correlates with time at which sodium reab-
sorption is among the highest. In addition, mice devoid of
CRY1 and CRY2 are displaying blunted circadian variation of
NHE3 expression [35, 36].
Further evidence of the role of the molecular clock in
sodium handling was brought forward by Gumz et al. [37].
The expression of the gene PER1, one of the transcription
factors of the negative limb of the molecular clock, is directly
regulated by aldosterone at submicromolar doses. Subsequent
studies linked PER1 to the regulation of the α subunit of
αENaC, in vitro in models of the collecting duct and in vivo in
the renal cortex and inner and outer medulla. Inhibition of
PER1 in cell lines issued from the collecting duct and in vivo
in PER1(−/−) mice led to an aldosterone-independent de-
creased expression of αENaC, the main channel involved in
sodium reabsorption in the connecting tubule and CCD.
PER1(−/−) mice displayed increased urinary sodium loss at
steady state, even though the cause is probably not exclusively
renal as it would be incompatible with the normal growth of
these mice [37, 38].
Using a pharmacological inhibitor of casein kinase 1δ/ɛ to
prevent PER1 nuclear localization, a role for PER1 in the regu-
lation of ENaC activity was recently corroborated [39]. A can-
didate gene approach to identify additional PER1 target genes
in renal collecting duct cells showed that PER1 coordinately
regulates a set of genes, including ET-1, encoding products
that function to regulate renal sodium reabsorption [40].
A recent study provided the ﬁrst evidence that the HKα2 is
regulated and functions in a circadian manner [41]. It was shown
that HKα2 mRNA ﬂuctuated with a small amplitude between
the active and rest phase in WT mice. Mice lacking HKα2
appeared to have a disrupted rhythm of plasma potassium.
It is tempting to speculate that the circadian clock-
controlled genes so far identiﬁed in the kidney are regulated by
the core clock proteins at a transcriptional level. This mechan-
ism of regulation has only been conﬁrmed for NHE3 [35] and
αENaC [37]. It is likely that other mechanisms are also in-
volved. One possible mechanism for regulation of renal epi-
thelial transporters is by circadian modulatory nuclear
receptors. Crambert et al. recently devised a map of nuclear
receptor expression along the nephron by assaying mRNA
expression of this gene family in isolated nephron segments
[42]. Interestingly, among the most highly expressed nuclear
receptors in the whole kidney were REV-ERBα and REV-
ERBβ. These two receptors modulate the expression of
BMAL1 and likely contribute to the regulation of a myriad of
clock target genes. The GR was also expressed along the entire
nephron. GR has often been linked to circadian clock function
[43] with studies showing a direct interaction between CRY2
and GR [44]. As part of their characterization of nuclear recep-
tor expression along the nephron, Crambert et al. demon-
strated that ERRβ was expressed predominantly in the thick
ascending limb. Using whole kidney RNA, they showed that
ERRβ expression was circadian with a peak of expression at ZT4.
Circadian variation was lost in mice lacking a functional CLOCK
gene. In subsequent in vitro studies, this group demonstrated
that in vivo inhibition of ERRβ resulted in decreased NKCC2
expression at the mRNA and protein levels [42].
Renal phenotypes in circadian mutant rodent models
In order to address more speciﬁcally the role of the molecu-
lar clock in renal physiology, mouse models with deletion of
transcription factors of the positive limb (CLOCK, BMAL1) or
of the negative limb (PERs and CRYs) of the molecular clock
were studied. However, due to ubiquitous expression of the
components of the molecular clock, the phenotypes of these
mice are complex. Indeed, BMAL1 knockout mice have, for in-
stance, deregulated food behavior and are infertile due to
altered testosterone production [45]. Moreover, they present
dilated cardiomyopathy [46], a ﬁnding consistent with the
phenotype reported in mice in which three output genes of the
molecular clock (DBP, HLF and TEF) were deleted in a sophis-
ticated triple knockout model and found with cardiac hyper-
trophy despite low aldosterone and renin levels [47]. This
illustrates the variety of phenotypes encountered in these mice
and the difﬁculty of studying the effects of a single component
of the molecular clock, such as BMAL1, in the kidney of a
mouse in which blood pressure, hormone levels and liver
metabolism are disturbed. However, and due to the weak
expression of CLOCK in the suprachiasmatic nucleus, largely
replaced by NPAS2 in this localization, CLOCK knockout mice
have milder alteration of their feeding behavior, making them
a more suitable model for studying peripheral clock function.
However, they also become obese and develop full metabolic
syndrome over time [48].
CLOCK-deﬁcient mice showed altered water and sodium
handling with increased urinary volume, lower urine osmolal-
ity, increased hematocrit and increased water consumption
F IGURE 2 : The clock-controlled genes driving kidney function in
the different segments of the nephron. The genes NHE3 and αENaC
are regulated by the core clock proteins at a transcriptional level.
An oscillation with a small amplitude between the active and rest
phase was evidenced for HKα2mRNA in wild-type mice.
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[33]. Altogether, these mice displayed a slight degree of ne-
phrogenic diabetes insipidus. Moreover, these mice exhibited
dysregulation of sodium handling resulting in lower blood
pressure, with preserved circadian dipping of blood pressure.
Implication of circadian variations of aldosterone levels in
the regulation of sodium and blood pressure has been bril-
liantly demonstrated by Doi et al.[49]. They showed that mice
devoid of CRY1/2 have increased blood pressure upon high-
salt diet associated with increased aldosterone levels and sup-
pressed renin. They identiﬁed the gene HSD3B6 in mice
(human ortholog is HSD3B1) as a pivotal enzyme regulating
aldosterone synthesis under control of the molecular clock.
Thus, suppression of the negative limb of the molecular clock
results in increased synthesis of the enzyme HSD3B6, leading
to high aldosterone production and salt-sensitive hyperten-
sion. Of note, circadian dipping of blood pressure was lost in
these mice, a phenotype consistent with the one from PER2
knockout mice, which harbor attenuated dipping [50].
However, models in which the positive limb of the molecular
clock (BMAL1 or CLOCK) was deleted, and the HLF, TEF,
DBP triple knockout mouse present low blood pressure, but
preserved nocturnal dipping. Altogether, these data show a pro-
minent role of the molecular clock in controlling aldosterone
production and, thus, in regulating blood pressure, including
nocturnal dipping.
Regarding sodium handling and regulation of blood
pressure, another regulatory mechanism has been proposed
recently. By comparing renal transcriptomes of CLOCK-
deﬁcient mice with those of their wild-type littermates, Firsov
and his team [51] identiﬁed several transcripts involved in ara-
chidonic acid metabolism that are up- or down-regulated in
CLOCK-deﬁcient mice. These transcripts are coding mainly
for cytochrome P450 enzyme family involved in the formation
of 20-HETE, a compound that regulates renal sodium reab-
sorption as well as renal vascular tone, and a powerful
mediator of blood pressure control by the kidney. Indeed, 20-
HETE content of the kidney is showing circadian rhythmicity,
which is shifted in CLOCK-knockout mice. Microarray analy-
sis of whole kidney RNA samples isolated every 4 h over a 24-
h period demonstrated altered expression of several enzymes
in the super-family of cytochrome P450 enzymes. CLOCK
knockout mice exhibited lower serum levels of 20-HETE over
a 24-h period, a ﬁnding that was postulated to be a putative
mechanism for the lower blood pressure previously observed
in mice lacking a functional CLOCK protein. Moreover, renal
content and urinary levels of 20-HETE were lower in 24-h col-
lection in CLOCK (−/−) mice compared with wild type. Taken
together, these results identiﬁed CLOCK as an important regu-
lator of arachidonic acid metabolism and as new controller of
blood pressure.
Further investigation of renal function and blood pressure
in CLOCK mutant mice has yielded important clues about the
role of this clock gene in the kidney. As previously reviewed
[52], Zuber et al. [33] demonstrated that CLOCK KO mice ex-
hibited lower blood pressure compared with wild-type mice
and this phenotype was accompanied by a mild diabetes insi-
pidus. In a follow-up study, Nikolaeava et al. [51] extended
these ﬁndings to show that the circadian rhythm of urinary
sodium excretion was disturbed in CLOCK knockout mice.
Of note, CLOCK knockout mice had a higher urinary Na
excretion rate over 24 h compared with wild-type mice.
Interestingly, a recent report [51] showed that PER1 knock-
out mice have a similar blood pressure phenotype as the
CLOCK knockout mice. Indeed, PER1 knockout mice exhib-
ited a 24-h mean blood pressure that was 18 mmHg less than
wild-type mice. PER1 knockout mice also had elevated levels
of inner medullary ET-1 compared with WT mice. Given the
known role of ET-1 in mediating the inhibition of ENaC and
regulation of blood pressure [53, 54], the observation of in-
creased ET-1 in PER1 knockout mice provided one possible
mechanism that may contribute to the blood pressure pheno-
type in these mice.
THE CLOCK GENE MACHINERY IN RENAL
PATHOLOGY
The alteration of the circadian clock circuitry is responsible for
derangement of physiological functions and behavioral pat-
terns, leading to disruption of anatomical integrity and disease
onset. On the other hand, inappropriate matching of environ-
mental/social cues and behavioral cycles caused by shift work,
jet-lag in transoceanic ﬂight attendants or sleep disturbances,
leading to sleep curtailment and mistiming, perturbs the
proper temporal organization of biological rhythms and rep-
resents a risk factor for a number of diseases.
As mentioned above, casein kinase 1δ/ɛ regulates nuclear
entry of the Period proteins. Tau mutant hamsters have a gain
of function mutation in casein kinase Iɛ and exhibit a de-
creased circadian period relative to wild-type hamsters. The
experimental model represented by a short-period mutation of
the circadian system in the hamsters (Mesocritetus auratus;
tau) provides evidence that rhythm disorganization alters
cardiovascular and renal integrity [55]. Heterozygous tau
mutants have a severe cardio-renal phenotype characterized
by cardiomyopathy, hypertrophy with extensive cardiac ﬁbro-
sis, severely impaired contractility, severe renal disease with
proteinuria, tubular dilation and cellular apoptosis, leading to
early death [55]. Renal dysfunction was evident as these inves-
tigators observed glomerular ischemia, tubular dilation, protei-
nuria and cellular apoptosis. Removal of the central clock in
the SCN led to abolition of the cardiac hypertrophy phenotype
in the tau mutants. Interestingly, maintaining the tau mutant
hamsters on a shortened light:dark cycle, consistent with their
inherent rhythm, resulted in correction of the cardio-renal
phenotype and a normal life span [55].
Above and beyond genetic mutations, the functioning of
the clock gene machinery in the kidney is inﬂuenced by
several factors. As reported above, the light and food cues
affect the circadian rhythm of the renal clock, but the feeding-
induced circadian resetting of the renal clock suggests a weak
synchronization effect of the food cue on the renal circadian
clock, whereas the re-entrainment of the clock genes is signiﬁ-
cantly improved after the reversal of both the feeding schedule
and the light/dark cycle [31, 32]. On the other hand, daytime
restricted feeding signiﬁcantly altered the expression patterns
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of DEC1 and DEC2, inducing circadian expression of DEC1
with an amplitude of 2-folds after 3 days and 4-folds after 7
days, whereas the expression of DEC1 but not DEC2 reverted
to being arrhythmic with a reversed feeding schedule coupled
with a reversed light/dark cycle. The exogenous injection at
certain times of the day of dexamethasone, a glucocorticoid
analogue, resulted in rhythmic expression of DEC1 similar to
that seen following 7 days of restricted feeding, suggesting the
existence of a glucocorticoid gating mechanism in the circa-
dian expression of DEC1 in rat kidney [56]. Feeding young
adult male BALB/cAn mice with a high-salt diet ad libitum for
over 2 weeks increased glucose absorption and altered the food
entrainment of peripheral biological clocks, advancing the
phase of clock gene expression by ∼3 h in the liver, kidney,
and lung, without changing circadian rhythmicty of feeding,
drinking and locomotor activity [57]. Furthermore, male
C57BL/6 mice fed a high-fat diet for more or less 1 year to
induce obesity, hyperglycemic, hypercholesterolemic and hy-
perinsulinemic symptoms, showed distorted liver and/or
kidney expression of clock genes and clock-controlled genes,
suggesting that obesity and metabolic syndrome inﬂuence the
functioning of the biological clock and the downstream circa-
dian output genes [5].
In rodents and humans, a time-related pattern with day/
night changes characterizes micturition frequency, and the cir-
cadian rhythmicity is maintained by the genetically encoded
biological clock system linking brain, kidney and bladder and
controlling urine volume, functional bladder capacity and uro-
dynamics. Mammals urinate less frequently during the sleep/
rest period than during the wake/activity period, and this
difference is driven by a combination of three factors: de-
creased arousal level in the brain, decreased urine production
rate from the kidneys and increased functional bladder
capacity during sleep. The most frequently used animal
models, such as rats and mice, are nocturnal animals and
show decreased micturition frequency during daytime, and
mice with genetically defective circadian clock system show
impaired physiological rhythms in these three factors. Simi-
larly, in humans diurnal functional changes in kidney and
bladder have been evidenced by several behavioral studies, and
in opposition, patients with nocturnal enuresis and nocturia
show impairment of these factors. These evidenced pinpoint
to a key role played by the circadian clock circuitry and the
linkage among the biological clocks in the brain, driving
arousal and behavioral patterns, in the kidney, regulating
water and electrolyte balance, and in the bladder, controlling
output genes such as connexin 43, a gene associated with regu-
lation of bladder capacity [58].
The renal biological clock and hypertension
The clock gene machinery plays a key role in the control of
blood pressure, driving locomotor activity, metabolic pro-
cesses, ﬂuid balance and vascular resistance, whose cyclic regu-
lation is driven by the circadian expression of genes encoding
enzymes and regulators involved in homeostatic processes at
body level and in the kidney [59], while derangements of circa-
dian clock-controlled mechanisms contribute to hypertension
onset and maintenance [60]. For example, an important role
in the regulation of salt balance and blood pressure is played
by WNK-OSR1/SPAK-NCC signal cascade, which shows cir-
cadian rhythms of protein phosphorylation and activity con-
trolled by aldosterone in the kidneys of male C57BL/6J mice
[61]. As reported above, in CLOCK (−/−) mice severe derange-
ments of numerous mechanisms, in particular the enzymatic
system engaged in the formation of ω-hydroxylated arachido-
nic acid metabolites, involved in maintaining sodium balance,
have been evidenced by renal circadian transcriptome analysis,
leading to alteration of the circadian rhythm of renal sodium
excretion and plasma aldosterone levels [51]. Besides, altered
expression of the clock genes PER2, BMAL1, CLOCK and DBP
was evidenced in the SCN, rostral ventrolateral medulla,
nucleus of the solitary tract, heart and kidney in an animal
model of genetic hypertension, the transgenic hypertensive
TGR(mREN-2)27 rat, which has the mouse salivary REN-2
gene integrated into its genome and is characterized by inverse
circadian blood pressure proﬁle with fulminant hypertension,
unchanged rhythmic pattern of heart rate and increased rela-
tive heart weight [62, 63]. As reported above, the simultaneous
deletion of all three PAR bZip transcription factors leads to in-
creased morbidity and shortened life span, a cardiorenal al-
teration associated with a low blood pressure and low
aldosterone levels [47], and exhibit signiﬁcant changes in renal
expression of several key regulators of water or sodium
balance, leading to a complex phenotype characterized by
partial diabetes insipidus, dysregulation of sodium excretion
rhythms and a signiﬁcant decrease in blood pressure [33].
A signiﬁcant circadian variation has been shown to charac-
terize blood pressure, inﬂuenced by a variety of external
factors, such as environmental–social cues and by internal
factors, such as ethnicity, gender, autonomic nervous system
tone, vasoactive hormones, hematologic and renal variables.
The time-related proﬁle of blood pressure levels shows a
morning increase, a small post-prandial valley and a deeper
descent during nocturnal rest, with a 10–20% drop during the
night in healthy subjects, whereas patients with secondary
hypertension frequently display abnormal circadian blood
pressure proﬁles, characterized by a failure to decrease blood
pressure at night [64]. In patients with the salt-sensitive type
of hypertension or chronic kidney disease the nighttime drop
is not evident, leading to the so-called ‘non-dipper’ pattern, re-
quiring different ingestion-time-dependent therapeutic strat-
egies, as evidenced by clinically signiﬁcant dissimilarity with
bedtime ingestion in the safety, efﬁcacy, duration of action
and/or effects on the 24-h blood pressure pattern of hyperten-
sion medications (angiotensin-converting enzyme inhibitors,
angiotensin-II receptor blockers, calcium-channel blockers, α-
blockers, β-blockers and diuretics) [65]. Decreased ultraﬁltra-
tion capacity or enhanced tubular sodium reabsorption causes
loss of renal functional reserve and provoke the salt-sensitive
type of hypertension. The failing sodium excretory capability
leads to nocturnal hypertension, a risk factor for cardiovascu-
lar events, which compensates for diminished natriuresis
during the daytime and enhances pressure natriuresis during
the night, but elevates glomerular capillary pressure leading to
glomerular sclerosis and in due course to renal failure [66].
On the other hand, renal function and blood pressure levels
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do not seem to inﬂuence the circadian rhythm of urinary pot-
assium excretion, which is correlated with that of urinary
sodium excretion [67]. Angiotensin receptor blocker treatment
increases the urinary sodium excretion during the daytime
and reverts the non-dipper blood pressure rhythm into a
dipper pattern. Furthermore, the circadian rhythm of urinary
potassium excretion is not determined by changes in aldoster-
one, blood pressure or creatinine clearance, but is determined
by the rhythm of urinary sodium excretion during treatment
with angiotensin receptor blockers, determining unchanged
whole-day urinary sodium excretion and diminished whole-
day urinary potassium excretion [68].
The extent of derangement in renal function may be
reliably appraised by means of evaluation of excretory function
together with proteinuria, providing independent relationships
of estimated glomerular ﬁltration rate and proteinuria with the
circadian variation and the mean level of blood pressure. The
mean level of systolic and diastolic blood pressure increases
with increasing severity of proteinuria as well as with increas-
ing impairment in glomerular ﬁltration rate, with a graded
relationship of proteinuria and glomerular ﬁltration rate with
the mean level of blood pressure and a non-graded relation-
ship with circadian variation [69]. In children affected by
chronic glomerulopathy with reduced creatinine clearance the
24-h urine volume output, urine creatinine and urine sodium
excretion were comparable to those observed in children af-
fected by chronic glomerulopathy with normal creatinine
clearance, but they showed greater proteinuria, arterial hyper-
tension and nocturnal polyuria. Besides, the nocturnal decline
in creatinine clearance, urine volume output, urine sodium
excretion and proteinuria were signiﬁcantly attenuated and the
nighttime mean arterial pressure, as well as the night/day
ratios of mean arterial pressure, urine volume output, urine
sodium excretion and proteinuria showed negative associ-
ations with creatinine clearance [70].
The circadian clock circuitry in kidney disease
Severe alterations of sleep quality, timing and duration are
characteristic of chronic kidney disease. Studies performed in
an animal model of chronic kidney disease represented by the
5/6th nephrectomized Sprague–Dawley rat have put in evi-
dence sleep disturbances, with the increase of both slow wave
sleep and rapid-eye movement sleep in the middle part of the
dark period, and the mRNA expression of clock genes PER1
and PER2 was up-regulated in the hypothalamus [71]. Circa-
dian sleep–wake cycle disturbances frequently lessen the
quality of life in individuals with end-stage renal disease, and
sleep disorders, caused both by the pathology of the renal
disease and by the dialysis treatment itself, are much more
prevalent in the dialysis population than in the general popu-
lation, impinging greatly on the vitality and general health of
these patients. The effect of dialysis, medications and bio-
chemical parameters may represent external and internal
inﬂuences on sleep–wake rhythmicity in patients with end-
stage renal disease [72]. Comparative data on sleep–wake
rhythms in different dialysis groups have been reported by a
study that examined sleep–wake parameters measured with
actigraphy and sleep questionnaires as well as melatonin
rhythms in automated peritoneal dialysis, conventional
daytime hemodialysis and nocturnal hemodialysis patients.
Conventional daytime dialysis patients had the worst sleep, a
normal nocturnal melatonin rise was found in nocturnal he-
modialysis patients, whereas this rise was absent in daytime
hemodialysis and automated peritoneal dialysis patients [72].
Another study reported improvements in polysomnography,
sleep quality/efﬁciency and deep sleep, rapid-eye-movement
sleep, awake time, and oxygen saturation and partial rescue of
nocturnal melatonin surge after 6 months of in-center noctur-
nal hemodialysis therapy [73]. The evidence draws attention
to the urgent need for intervention strategies to effectively
strengthen the synchronization of the circadian sleep–wake
rhythm, such as nocturnal hemodialysis, dialyzate tempera-
ture, use of bright light and exercise during dialysis treatment,
exogenous erythropoietin and exogenous melatonin [74, 75].
Chronic kidney disease by itself alters the endocrine secretory
output of the circadian timing system. In this regard, the am-
plitude of melatonin rhythm decreases with advancing renal
dysfunction [76] and the administration of exogenous melato-
nin (3 mg at 22.00 h every night) improves subjective and ob-
jective sleep parameters, rescuing nocturnal melatonin rhythm
in hemodialysis patients [74]. On the other hand, renal func-
tion does not seem to associate with cortisol rhythm par-
ameters, and no association could be detected between the
phases of the rhythms of melatonin and cortisol [77]. Substan-
tial disagreement originated from the evaluation of the hypo-
thalamic–pituitary–adrenal axis function in patients with
chronic kidney disease, and in this patient population the di-
agnosis of anomalous glucocorticoid metabolism can be not
simple. The excretion of cortisol and its water soluble metab-
olites depends on normal kidney function, and in advanced
renal failure there is lengthening of cortisol serum half-life
[78], cortisol binding to corticosteroid-binding globulin
remains normal, while binding to albumin is decreased, and
compounds comprising cortisol metabolites accumulate, inter-
fering with cortisol measurement, so that methodological pro-
blems produce conﬂicting results, and both normal and
elevated levels of serum cortisol are described [79, 80]. The
features of endogenous hypercortisolism may be present in
patients with end-stage renal disease, and when evaluations of
cortisol and ACTH were performed in plasma and salivary
samples drawn frequently over 24 h in subjects on daytime
chronic hemodialysis, higher nadir in plasma and salivary cor-
tisol and plasma ACTH secretion was evidenced, so that end-
stage renal disease patients had increased late-night plasma
and salivary cortisol and plasma ACTH levels when compared
with controls [81].
The functioning of the clock gene machinery has been eval-
uated in patients affected by kidney cancer, and the expression
of a number of clock genes was altered [82]. Down-regulation
was evidenced in tumor tissue when compared with matched
non-tumorous tissue for PER2, involved in susceptibility to
DNA damage-induced carcinogensis, and for TIMELESS and
TIPIN, which in conjunction with PER2 interact with cell
cycle checkpoints and take part in the response to DNA
damage. On the contrary, up-regulation was evidenced for
ARNTL2 and the downstream target gene SERPINE1,
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encoding the (PAI-1), seemingly implicated in hypercoagul-
ability state and increased frequency of thrombotic events,
such as mono or bilateral renal vein thrombosis, which inﬂu-
ence overall survival in kidney cancer patients [82]. The altera-
tion of the clock gene machinery evidenced in kidney cancer
and the control of cellular proliferation and drug metabolism
over the 24 h by circadian clocks open the way to therapeutic
approaches that take into account the temporal dimension of
drug administration, i.e. chronotherapy, based on timing models
to optimize the scheduling of anti-cancer drugs, with the aim to
deal with the rhythm of both the anti-cancer action of drugs,
and that of drug-related side effects on normal cells [83].
CONCLUSION
Kidney functions, such as hydro-electrolytic and acid-base
balance regulation, small solutes reabsorption and hormone
production, are characterized by diurnal changes and contrib-
ute to circadian variability of blood pressure and to daily oscil-
lation in body homeostasis. The circadian clock circuitry
drives the rhythmicity of renal physiology controlling
nychthemeral changes of sodium sensitivity, vascular tone,
autonomic function and neurotransmitter release from sym-
pathetic innervations, as well as behavioral cycles of rest/
activity and sleep–wake. The mismatch between environ-
mental–social cues and physiological–behavioral patterns,
triggers physiopathological mechanisms involved in renal
pathology. During the last years, numerous advances have pro-
vided a better understanding of the role of the molecular
clockwork on renal function, especially in the control of salt
and blood pressure, and of biological clock derangements in
renal disease. Other ﬁelds of renal physiology, known to
harbor circadian cyclicity, as well as renal pathology, related to
desynchronization of periodic functions, need to be explored.
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